Gloria Bonuccelli

Gloria Bonuccelli

Auto-generated profile, based on publicly available information

Gloria Bonuccelli

Translational Medicine, School of Environment and Life Sciences, Biomedical Research Centre (BRC), University of Salford, Greater Manchester, UK

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Cell Cycle
Verified
Journal Article
Open access
GBGloria Bonuccelli
Gloria Bonuccelli
ATAristotelis Tsirigos
Aristotelis Tsirigos
DWDiana Whitaker-Menezes
Diana Whitaker-Menezes
SPStephanos Pavlides
Stephanos Pavlides
RPRichard G. Pestell
Richard G. Pestell
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
Previously, we proposed a new model for understanding the "Warburg effect" in tumor metabolism. In this scheme, cancer-associated fibroblasts undergo aerobic glycolysis and the resulting energy-ric...

15 June 2012 in Cell Cycle
Verified
Journal Article
Open access
CCClaudia Capparelli
Claudia Capparelli
CGCarmela Guido
Carmela Guido
DWDiana Whitaker-Menezes
Diana Whitaker-Menezes
GBGloria Bonuccelli
Gloria Bonuccelli
RBRenee Balliet
Renee Balliet
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
Senescent fibroblasts are known to promote tumor growth. However, the exact mechanism remains largely unknown. An important clue comes from recent studies linking autophagy with the onset of senesc...

15 May 2010 in Cell Cycle
Verified
Journal Article
Closed access
PDF file
GBGloria Bonuccelli
Gloria Bonuccelli
DWDiana Whitaker-Menezes
Diana Whitaker-Menezes
RCRemedios Castello-Cros
Remedios Castello-Cros
SPStephanos Pavlides
Stephanos Pavlides
RPRichard G. Pestell
Richard G. Pestell
MLMichael P. Lisanti
Michael P. Lisanti
We and others have previously identified a loss of stromal caveolin-1 (Cav-1) in cancer-associated fibroblasts (CAFs) as a powerful single independent predictor of breast cancer patient tumor recurrence, metastasis, tamoxifen-resistance, and poor clinical outcome. However, it remains unknown how loss of stromal Cav-1 mediates these effects clinically. To mechanistically address this issue, we have now generated a novel human tumor xenograft model. In this two-component system, nude mice are co-injected with i) human breast cancer cells (MDA-MB-231), and ii) stromal fibroblasts (wild-type (WT) versus Cav-1 (-/-) deficient). This allowed us to directly evaluate the effects of a Cav-1 deficiency solely in the tumor stromal compartment. Here, we show that Cav-1-deficient stromal fibroblasts are sufficient to promote both tumor growth and angiogenesis, and to recruit Cav-1 (+) micro-vascular cells. Proteomic analysis of Cav-1-deficient stromal fibroblasts indicates that these cells upregulate the expression of glycolytic enzymes, a hallmark of aerobic glycolysis (the Warburg effect). Thus, Cav-1-deficient stromal fibroblasts may contribute towards tumor growth and angiogenesis, by providing energy-rich metabolites in a paracrine fashion. We have previously termed this new idea the “Reverse Warburg Effect”. In direct support of this notion, treatment of this xenograft model with glycolysis inhibitors functionally blocks the positive effects of Cav-1-deficient stromal fibroblasts on breast cancer tumor growth. Thus, pharmacologically-induced metabolic restriction (via treatment with glycolysis inhibitors) may be a promising new therapeutic strategy for breast cancer patients that lack stromal Cav-1 expression. We also identify the stromal expression of PKM2 and LDH-B as new candidate biomarkers for the “Reverse Warburg Effect” or “Stromal-Epithelial Metabolic Coupling” in human breast cancers.

1 June 2008 in The American Journal of Pathology
Verified
Journal Article
Closed access
JAJunaid Abdulghani
Junaid Abdulghani
LGLei Gu
Lei Gu
ADAyush Dagvadorj
Ayush Dagvadorj
JLJacqueline Lutz
Jacqueline Lutz
BLBenjamin Leiby
Benjamin Leiby
MNMarja T. Nevalainen
Marja T. Nevalainen

1 November 2010 in Cell Cycle
Verified
Journal Article
Open access
UMUbaldo E. Martinez-Outschoorn
Ubaldo E. Martinez-Outschoorn
DWDiana Whitaker-Menezes
Diana Whitaker-Menezes
SPStephanos Pavlides
Stephanos Pavlides
BCBarbara Chiavarina
Barbara Chiavarina
GBGloria Bonuccelli
Gloria Bonuccelli
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
The role of autophagy in tumorigenesis is controversial. Both autophagy inhibitors (chloroquine) and autophagy promoters (rapamycin) block tumorigenesis by unknown mechanism(s). This is called the “Autophagy Paradox”. We have recently reported a simple solution to this paradox. We demonstrated that epithelial cancer cells use oxidative stress to induce autophagy in the tumor microenvironment. As a consequence, the autophagic tumor stroma generates recycled nutrients that can then be used as chemical building blocks by anabolic epithelial cancer cells. This model results in a net energy transfer from the tumor stroma to epithelial cancer cells (an energy imbalance), thereby promoting tumor growth. This net energy transfer is both unilateral and vectorial, from the tumor stroma to the epithelial cancer cells, representing a true host-parasite relationship. We have termed this new paradigm “The Autophagic Tumor Stroma Model of Cancer Cell Metabolism” or “Battery-Operated Tumor Growth”. In this sense, autopha...

1 August 2008 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
IMIsabelle Mercier
Isabelle Mercier
MCMathew C. Casimiro
Mathew C. Casimiro
CWChenguang Wang
Chenguang Wang
ARAnne L. Rosenberg
Anne L. Rosenberg
JQJudy Quong
Judy Quong
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
It is becoming increasingly apparent that the tumor micro-environment plays a critical role in human breast cancer onset and progression. Therefore, we isolated cancer-associated fibroblasts (CAFs)...